Examining Critical Gaps in AF Stroke Prevention – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Alexander Benz et al, adding:
“Antithrombotic Therapy in Patients with Atrial Fibrillation: Unresolved Issues and Future Directions
This review examines critical gaps in AF stroke prevention, including limitations of current risk scores, populations where vitamin K antagonists remain preferred, uncertain net benefit in special groups, and the emerging promise of factor XI inhibitors for safer anticoagulation.”
Title: Antithrombotic therapy in patients with atrial fibrillation: unresolved issues and future directions
Authors: Alexander Benz, Stephanie Carlin, John Eikelboom
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 11:52Prakash W. Kamat: Highlighting the Role of Physical Activity in Hemophilia Management
-
May 22, 2026, 11:43Mohamed Hanafy Morsy: Understanding Hemochromatosis – Genetics Made Simple
-
May 22, 2026, 10:23Rucha Patil: Insights from The National Haemophilia Conclave 2026
-
May 22, 2026, 10:11Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
-
May 22, 2026, 10:02Greta Mulders: Nursing Leadership in Haemophilia Gene Therapy
-
May 22, 2026, 08:45Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS
-
May 22, 2026, 08:35Jason Brandon: On Lyophilized Hemostatic Supplementation at Simmons Research Day 2026
-
May 22, 2026, 08:28Inconsistent D-Dimer Assay Reporting in VTE Studies – JTH
-
May 22, 2026, 08:21Vincent Jongkind: We Invite You to Participate in a Delphi Study for a Core Outcome Set in Acute Limb Ischemia